Nomura Asset Management
EBS icon

Nomura Asset Management’s Emergent Biosolutions EBS Stock Holding History

Nomura Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,200
Closed -$8.82K – 1551
2023
Q2 		$8.82K Hold
1,200
– – ﹤0.01% 1513
2023
Q1 		$12.4K Buy
+1,200
New +$14.5K ﹤0.01% 1491
2022
Q4 		– Sell
-390
Closed -$8.19K – 1513
2022
Q3 		$8.19K Hold
390
– – ﹤0.01% 1499
2022
Q2 		$12.1K Hold
390
– – ﹤0.01% 1481
2022
Q1 		$16K Buy
+390
New +$17.2K ﹤0.01% 1479

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nomura Asset Management's EBS Position: Q3 2023 in Review

Nomura Asset Management sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 1,200 shares — an estimated $8.82K sold.

Nomura Asset Management first reported a position in EBS in Q1 2022 and held it in 5 quarters. The position peaked at $16K in Q1 2022. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

  • Nomura Asset Management reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
  • Nomura Asset Management sold 1,200 Emergent Biosolutions shares in Q3 2023, an estimated $8.82K.
  • Nomura Asset Management first reported a position in Emergent Biosolutions in Q1 2022 and held it in 5 quarters.
  • Nomura Asset Management's Emergent Biosolutions position peaked at $16K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Nomura Asset Management's 13F filing for Q3 2023, filed 3 Nov 2023.